Related Experiment Video
Updated: Jul 20, 2026
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Human malignant mesothelioma: molecular mechanisms of pathogenesis and progression
Enrico P Spugnini1, Silvano Bosari, Gennaro Citro
1SAFU Department, Regina Elena National Cancer Institute, Rome, Italy.
Abstract:
The continuing identification and elucidation of the molecular defects involved in mesothelioma pathogenesis and progression should lead to better disease control and greater therapeutic options in the near future. Goal of this review article is to summarize the most recent advances in molecular pathogenesis of mesothelioma and discuss possible therapeutic implications of these findings.
Insights
Identifying molecular defects in mesothelioma pathogenesis offers new therapeutic strategies. Understanding these molecular changes is key to improving disease control and treatment options for mesothelioma patients.
Area of Science:
- Oncology
- Molecular Biology
- Pathogenesis Research
Background:
- Malignant mesothelioma is an aggressive cancer with limited treatment options.
- Understanding the molecular underpinnings of mesothelioma is crucial for therapeutic advancement.
Purpose of the Study:
- To review recent progress in understanding the molecular pathogenesis of mesothelioma.
- To discuss the therapeutic implications of these molecular discoveries.
Main Methods:
- Literature review of recent scientific publications.
- Synthesis of current knowledge on mesothelioma molecular defects.
- Analysis of potential therapeutic targets and strategies.
Main Results:
- Advances in identifying specific molecular alterations driving mesothelioma.
- Elucidation of key pathways involved in mesothelioma progression.
- Emerging molecular targets for novel mesothelioma therapies.
Conclusions:
- Continued research into mesothelioma's molecular defects will improve disease management.
- Molecular insights are paving the way for more effective mesothelioma treatments.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...